INTRODUCTION
Recent developments in the technology have presented viable dosage alternatives from oral route for pediatrics, geriatric, bedridden, nauseous or noncompliant patients. Buccal drug delivery has lately become an important route of drug administration. Various bio adhesive mucosal dosage forms have been developed, which includes adhesive tablets, gels, ointments, patches and more recently the use of polymeric films for buccal delivery. The most popular solid dosage forms are being tablets and capsules. The conventional tablet seems to be most popular because of its ease of transportability and comparatively low manufacturing cost but poor patient compliance in case of pediatrics and geriatrics patients because of hand tremors and dysphasia that experienced difficulties in swallowing. Often times people experience inconvenience in swallowing conventional dosage forms such as tablet when water is not available, in the case of the motion sickness (kinetosis) and sudden episodes of coughing during the common cold, allergic condition and bronchitis. To overcome these problems, scientists have developed innovative drug delivery system known as fast dissolving/disintegrating tablets (FDTs). These are novel types of tablets that dissolve/ disintegrate/ disperse in saliva within few seconds. The Centre for Drug Evaluation and Research (CDER), US FDA defined fast dissolving/ disintegrating tablets (FDT) as "A solid dosage form containing medicinal substances, which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue".
Drugs release from FDT get absorbed from the oral cavity, pharynx and esophagus as the saliva passes down into the stomach. Dispersion of tizanidine hydrochloride in saliva in oral cavity causes pre-gastric absorption of drug which dissolves. Any pre-gastric absorption avoids first pass hepatic metabolism which also increases bioavailability.
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Tizanidine hydrochloride is an Imidazoline derivative which acts as agonist on centrally located α 2 receptors and this leads to myotonolytic effects on skeletal muscle. It is structurally and pharmacologically similar to Clonidine and other α-2 adrenergic agonists. It is given with a dose of 2-4 mg. About 53-66% of the dose administered is being absorbed through the gastrointestinal tract after oral administration and the peak plasma concentration is reached within 1 to 2 hrs. Bioavailability of Tizanidine is about 34-40% and half life is 2.5 hrs. The drug is widely distributed throughout the body and 30% of drug binds to plasma proteins. It undergoes rapid and extensive first pass metabolism in the liver (approximately 95% of a dose), leading to the oxidation of the Imidazole moiety, aromatic system and the sulphur atom. This leads to lower bioavailability of Tizanidine hydrochloride. It is a white to off white, fine crystalline powder, which is odourless or with faint characteristic odour. It is slightly soluble in water and methanol, solubility in water decreases as the pH increases. Its chemical IUPAC name is 5-Chloro-4-(2-Imidazolin-2-ylamino)-2,1,3-benzothiodiazole hydrochloride. 
MATERIALS AND METHODS

MATERIALS
METHODS
Direct compression method:
Fast dissolving tablets of tizanidine hydrochloride were prepared by direct compression method. All the ingredients were passed through sieve no. 16. Then the ingredients were weighed and mixed in the plastic container in geometrical order and compressed into tablets of 100 mg.
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EVALUATION
1) PRE COMPRESSION PARAMETERS OF TIZANIDINE HYDROCHLORIDE FAST DISSOLVING TABLETS
The prepared blend was analyzed for angle of repose, bulk density, tapped density, compressibility index and Hausner's ratio. Determination of bulk density and tapped density:
Flow Properties
Carr's Index (Compressibility): The compressibility index is the measure of property of powder to be compressed. The packing ability of drug was evaluated from change in volume, which is due to rearrangement of packing occurring during tapping. It was indicated as Carr's compressibility index.
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Hausner Ratio: It is measurement of frictional resistance of the drug. The ideal range should be 1.2-1.5. It was determined by the ratio of tapped density and bulk density.
Angle of Repose: It is defined as the maximum angle that can be obtained between the free standing of powder heap and horizontal plane. Weighed quantity of the drug was passed through a funnel kept at a height 2 cm from the base. The powder was passed till it forms a heap and touches the tip of the funnel. The radius was measured and angle of repose was calculated. 
2) DRUG -EXCIPIENTS COMPATIBLITY STUDIES Fourier Transform Infrared Spectroscopy (FT-IR):
The Fourier-transform infrared spectra of tizanidine hydrochloride and mixture of tizanidine hydrochloride with other excipients were obtained by using FTIR spectroscopy (Shimadzu, Japan). The samples were crushed with KBr to get pellets by applying pressure of 600 Kg/cm 2 . 8
3) POST COMPRESSION PARAMETERS OF TIZANIDINE HYDROCHLORIDE FAST DISSOLVING TABLETS
Evaluation parameters of tablets mention in the Pharmacopoeias need to be assessed, along with some special tests which are discussed here. Friability: Friability of the tablet determined using Roche friabilator. This device subjects the tablet to the combined effect of abrasion and shock in a plastic chamber revolving at 25 rpm and dropping a tablet at a height of 6 inches in each revolution. Pre weighted sample of tablets was placed in the friabilator and were subjected to the 100 revolutions. Tablets were de-dusted using a soft muslin cloth and reweighed. Thickness: The thickness and diameter of the tablets was determined using a Vernier calliper. Three tablets from each type of formulation were used and average values were calculated. It is expressed in mm.
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Water Absorption Ratio: A piece of tissue paper folded twice was kept in a Petri dish (internal diameter 5.5cm) containing 6ml of purified water. The tablet was placed on the tissue paper and allowed to wet completely. The wetted tablet was removed and reweighted.
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Wetting Time: A piece of tissue paper folded twice was placed in a small Petri dish containing 6ml pH 6.8 phosphate buffers. A tablet was placed on the paper and the time taken for complete wetting was noted.
Disintegration Study: In the Disintegration time study one tablet was placed in a beaker containing 10 ml of pH 6.8 phosphate buffers at 37 ± 0.5 0 C and the time required for complete dispersion was determined.
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Drug Content: Five tablets were randomly selected and average weight was calculated. Tablets were powdered in a glass mortar. Powder equivalent to 4 mg weight and dissolved in 100 ml of 6.8 pH buffer filtered and drug content analyzed spectrophotometrically at 230 nm.
In -Vitro Dissolution Testing: Dissolution study is conducted for all the formulation using USP type-II apparatus. The dissolution test is per-formed using 900ml of phosphate buffer (pH 6.8) is taken as the dissolution medium at 50 rpm and 37 ±0.5°C. Ten ml of aliquots were periodically withdrawn and the sample volume was replaced with an equal volume of fresh dissolution medium. The samples should be analyzed spectrophotometrically.
KINETIC RELEASE STUDIES OF DISSOLUTION DATA
Zero Order: It describes the systems where the drug release rate is independent of its concentration of the dissolved substance. A graph is plotted between the time taken on x-axis and the cumulative % of drug release on y-axis.
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First Order: The data obtained are plotted as log cumulative percentage of drug remaining vs. time .
RESULTS AND DISCUSSION
Fast dissolving tablets of tizanidine hydrochloride were prepared by direct compression method by using superdisintegrants like crospovidone, crosscarmellose sodium and sodium starch glycolate in varying amount (Table 1) . λ max of tizanidine in pH 6.8 was found to be at 230 nm as shown in Figure 1 . FT-IR studies: The FTIR spectra of the pure drug were recorded in between 4000 to 400 cm -1 . Characteristics peaks and chemical groups present in IR spectrum of tizanidine hydrochloride are shown in Figure 3 . The FT-IR spectra of tizanidine hydrochloride revealed the presence of characteristic broad and strong peak for C=N stretching around 1644.98 cm -1 , stretching peak around 3089. Table 3&4 . Dissolution Study in 6.8 pH phosphate buffer: Formulations TZN 1, TZN 2, TZN 3, TZN 
